Photodiagnosis and Photodynamic Therapy
Volume 2, Issue 3 , Pages 205-222 , September 2005

Clinical photodynamic therapy of head and neck cancers—A review of applications and outcomes

  • R.R. Allison

      Affiliations

    • PDT Center, Brody School of Medicine, East Carolina University, NC 27858, USA
    • Department of Radiation Oncology, Brody School of Medicine, East Carolina University, Greenville, NC 27858, USA
  • ,
  • R.E. Cuenca

      Affiliations

    • PDT Center, Brody School of Medicine, East Carolina University, NC 27858, USA
    • Department of Surgical Oncology, Brody School of Medicine, East Carolina University, USA
  • ,
  • G.H. Downie

      Affiliations

    • PDT Center, Brody School of Medicine, East Carolina University, NC 27858, USA
    • Department of Medicine, Pulmonary and Critical Care Medicine, Brody School of Medicine, East Carolina University, USA
  • ,
  • P. Camnitz

      Affiliations

    • East Carolina ENT, Head and Neck Surgery, Greenville, NC 27858, USA
  • ,
  • B. Brodish

      Affiliations

    • East Carolina ENT, Head and Neck Surgery, Greenville, NC 27858, USA
  • ,
  • C.H. Sibata, PhD

      Affiliations

    • PDT Center, Brody School of Medicine, East Carolina University, NC 27858, USA
    • Department of Radiation Oncology, Brody School of Medicine, East Carolina University, Greenville, NC 27858, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 252 744 2900; fax: +1 252 744 2812.

References 

  1. Vokes EE, Weichselbaum RR, Lippman SM, et al. Head and neck cancer. N Engl J Med. 1993;328(3):184–194
  2. Parsons JT, Mendenhall WM, Million RR, et al. The Management of primary cancers of the oropharynx: combined treatment or irradiation alone?. Semin Radiat Oncol. 1992;2(3):142–148
  3. Million R, Cassisi N. Management of head and neck cancer: a multidisciplinary approach. second ed.. Lippincott Williams and Wilkins; 1993;
  4. Langius A, Bjorvell H, Lind MG. Functional status and coping in patients with oral and pharyngeal cancer before and after surgery. Head Neck. 1994;16(6):559–568
  5. Cooper JS, Fu K, Marks J, et al. Late effects of radiation therapy in the head and neck region. Int J Radiat Oncol Biol Phys. 1995;31(5):1141–1164
  6. Fu KK. Combined-modality therapy for head and neck cancer. Oncology (Huntingt). 1997;11(12):1781–17901796; discussion 1796, 179
  7. List MA, Bilir SP. Functional outcomes in head and neck cancer. Semin Radiat Oncol. 2004;14(2):178–189
  8. Weinstein GS, El-Sawy MM, Ruiz C, et al. Laryngeal preservation with supracricoid partial laryngectomy results in improved quality of life when compared with total laryngectomy. Laryngoscope. 2001;111(2):191–199
  9. Eisbruch A, Marsh LH, Martel MK, et al. Comprehensive irradiation of head and neck cancer using conformal multisegmental fields: assessment of target coverage and noninvolved tissue sparing. Int J Radiat Oncol Biol Phys. 1998;41(3):559–568
  10. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. The Department of Veterans Affairs Laryngeal Cancer Study Group. N Engl J Med 1991;324(24):1685–90.
  11. Forastiere AA, Goepfert H, Maor M, et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med. 2003;349(22):2091–2098
  12. Savary M, Monnier P, Pasche R, et al. Multiple primary malignancies. Adv Otorhinolaryngol. 1991;46:165–175
  13. Gluckman JL, Crissman JD. Survival rates in 548 patients with multiple neoplasms of the upper aerodigestive tract. Laryngoscope. 1983;93(1):71–74
  14. Biel MA. Photodynamic therapy in head and neck cancer. Curr Oncol Rep. 2002;4(1):87–96
  15. Allison RR, Sibata C, Mang TS, et al. Photodynamic therapy for chest wall recurrence from breast cancer. Photodiagn Photodyn Ther. 2004;1(2):157–171
  16. Bagnato VS, Kurachi C, Ferreira J, et al. PDT experience in Brazil: a regional profile. Photodiag Photodyn Ther. 2005;2:107–118
  17. Parker SL, Tong T, Bolden S, et al. Cancer statistics. CA Cancer J Clin. 1997;47(1):5–27
  18. Allison RR, Mota HC, Sibata CH. Clinical PD/PDT in North America: an historical review. Photodiag Photodyn Ther. 2004;1(4):263–277
  19. Kessel D. Photodynamic therapy and neoplastic disease. Oncol Res. 1992;4(6):219–225
  20. Dougherty TJ. Photodynamic therapy. Photochem Photobiol. 1993;58(6):895–900
  21. Allison RR, Downie GH, Cuenca R, et al. Photosensitizers in clinical PDT. Photodiagn Photodyn Ther. 2004;1(1):27–42
  22. Von Tappeiner H, Jesionek A. Therapeutische Versuche mit fluoreszierenden Stoffen (Therapeutic experiments with fluorescent substances). Muench Med Wochenschr. 1903;47:2042–2044
  23. Dougherty TJ, Kaufman JE, Goldfarb A, et al. Photoradiation therapy for the treatment of malignant tumors. Cancer Res. 1978;38(8):2628–2635
  24. Bonnett R. New photosensitizers for the photodynamic therapy of tumors. Proc Soc Photo-Opt Instrum Eng. 1994;2078:74–90
  25. Brancaleon L, Moseley H. Laser and non-laser light sources for photodynamic therapy. Lasers Med Sci. 2002;17(3):173–186
  26. Mang T. Lasers and light sources for PDT: past, present and future. Photodiagn Photodyn Ther. 2004;1(1):43–48
  27. Dougherty TJ, Gomer CJ, Henderson BW, et al. Photodynamic therapy. J Natl Cancer Inst. 1998;90(12):889–905
  28. Henderson BW, Dougherty TJ. How does photodynamic therapy work?. Photochem Photobiol. 1992;55(1):145–157
  29. Dougherty TJ, Marcus SL. Photodynamic therapy. Eur J Cancer. 1992;10(42):1734–1742
  30. Kennedy JC, Pottier RH. Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy. J Photochem Photobiol B. 1992;14(4):275–292
  31. Bonnett R, White RD, Winfield UJ, et al. Hydroporphyrins of the meso-tetrahydroxyphenyl porphyrin series as tumors photosensitizers. Biochem J. 1989;261:277–280
  32. Sibata CH, Colussi VC, Oleinick NL, et al. Photodynamic therapy: a new concept in medical treatment. Braz J Med Biol Res. 2000;33(8):869–880
  33. Stringer M, Moghissi K. Photodiagnosis and fluorescence imaging in clinical practice. Photodiagn Photodyn Ther. 2004;1(1):9–12
  34. Andersson-Engels S, Klinteberg C, Svanberg K, et al. In vivo fluorescence imaging for tissue diagnostics. Phys Med Biol. 1997;42(5):815–824
  35. Clark AL, Gillenwater A, Alizadeh-Naderi R, et al. Detection and diagnosis of oral neoplasia with an optical coherence microscope. J Biomed Opt. 2004;9(6):1271–1280
  36. Wilson BC, Patterson MS, Lilge L. Implicit and explicit dosimetry in photodynamic therapy: a new paradigm. Lasers Med Sci. 1997;12:182–199
  37. Leonard JR, Beck WL. Hematoporphyrin fluorescence: an aid in diagnosis of malignant neoplasms. Laryngoscope. 1971;81(3):365–372
  38. Wang TD, Van Dam J. Optical biopsy: a new frontier in endoscopic detection and diagnosis. Clin Gastroenterol Hepatol. 2004;2(9):744–753
  39. Ackroyd R, Kelty C, Brown N, et al. The history of photodetection and photodynamic therapy. Photochem Photobiol. 2001;74(5):656–669
  40. Wilson BC. Photodynamic therapy for cancer: principles. Can J Gastroenterol. 2002;16(6):393–396
  41. Tan IB, Oppelaar H, Ruevekamp MC, et al. The importance of in situ light dosimetry for photodynamic therapy of oral cavity tumors. Head Neck. 1999;21(5):434–441
  42. Cuenca RE, Allison RR, Sibata C, et al. Breast cancer with chest wall progression: treatment with photodynamic therapy. Ann Surg Oncol. 2004;11(3):322–327
  43. Kubler AC, Haase T, Staff C, et al. Photodynamic therapy of primary nonmelanomatous skin tumours of the head and neck. Lasers Surg Med. 1999;25(1):60–68
  44. Lipson RL, Baldes EJ. The photodynamic properties of a particular hematoporphyrin derivative. Arch Dermatol. 1960;82:508–516
  45. Lipson RL, Baldes EJ, Olsen AM. The use of a derivative of hematoporhyrin in tumor detection. J Natl Cancer Inst. 1961;26:1–11
  46. Zhao FY, Zhang KH, Ma DK, et al. Treatment of 510 cases of oral squamous cell carcinoma. Ann Academ Med Singapore. 1989;18:533–536
  47. Dougherty TJ, Grindey GB, Fiel R, et al. Photoradiation therapy II. Cure of animal tumors with hematoporphyrin and light. J Natl Cancer Inst. 1975;55(1):115–121
  48. Keller GS, Doiron DR, Fisher GU. Photodynamic therapy in otolaryngology—head and neck surgery. Arch Otolaryngol. 1985;111(11):758–761
  49. Braichotte DR, Wagnieres GA, Bays R, et al. Clinical pharmacokinetic studies of photofrin by fluorescence spectroscopy in the oral cavity, the esophagus, and the bronchi. Cancer. 1995;75(11):2768–2778
  50. Schuller DE, McCaughan JS, Rock RP. Photodynamic therapy in head and neck cancer. Arch Otolaryngol. 1985;111(6):351–355
  51. Edge CJ, Carruth JA. Photodynamic therapy and the treatment of head and neck cancer. Br J Oral Maxillofac Surg. 1988;26(1):1–11
  52. Wenig BL, Kurtzman DM, Grossweiner LI, et al. Photodynamic therapy in the treatment of squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg. 1990;116(11):1267–1270
  53. Grossweiner LI, Hill JH, Lobraico RV. Photodynamic therapy of head and neck squamous cell carcinoma: optical dosimetry and clinical trial. Photochem Photobiol. 1987;46(5):911–917
  54. Freche C, De Corbiere S. Use of photodynamic therapy in the treatment of vocal cord carcinoma. J Photochem Photobiol B. 1990;6(3):291–296
  55. Schweitzer VG. Photodynamic therapy for treatment of head and neck cancer. Otolaryngol Head Neck Surg. 1990;102(3):225–232
  56. Schweitzer VG. Photofrin-mediated photodynamic therapy for treatment of early stage oral cavity and laryngeal malignancies. Lasers Surg Med. 2001;29(4):305–313
  57. Gluckman JL. Hematoporphyrin photodynamic therapy: is there truly a future in head and neck oncology? Reflections on a 5-year experience. Laryngoscope. 1991;101(1 Pt 1):36–42
  58. Grant WE, Hopper C, Speight PM, et al. Photodynamic therapy of malignant and premalignant lesions in patients with ‘field cancerization’ of the oral cavity. J Laryngol Otol. 1993;107(12):1140–1145
  59. Feyh J. Photodynamic therapy of head and neck tumors. Adv Otorhinolaryngol. 1995;49:53–57
  60. Feyh J. Photodynamic treatment for cancers of the head and neck. J Photochem Photobiol B. 1996;36(2):175–177
  61. Ofner JG, Bartl B, Konig S, et al. Photodynamic therapy in selected cases at the ENT Clinic Innsbruck: case reports. J Photochem Photobiol B. 1996;36(2):185–187
  62. Kulapaditharom B, Boonkitticharoen V. Photodynamic therapy in the treatment of head and neck cancers: a two-year experience. J Med Assoc Thai. 1996;79(4):229–235
  63. Kulapaditharom B, Boonkitticharoen V. Photodynamic therapy for residual or recurrent cancer of the nasopharynx. J Med Assoc Thai. 1999;82(11):1111–1117
  64. Kulapaditharom B, Boonkitticharoen V. Photodynamic therapy in management of head and neck cancers and precancerous lesions. J Med Assoc Thai. 2000;83(3):249–258
  65. Biel MA. Photodynamic therapy and the treatment of neoplastic diseases of the larynx. Laryngoscope. 1994;104(4):399–403
  66. Biel MA. Photodynamic therapy of head and neck cancers. Semin Surg Oncol. 1995;11(5):355–359
  67. Biel MA. Photodynamic therapy and the treatment of head and neck cancers. J Clin Laser Med Surg. 1996;14(5):239–244
  68. Biel MA. Photodynamic therapy as an adjuvant intraoperative treatment of recurrent head and neck carcinomas. Arch Otolaryngol Head Neck Surg. 1996;122(11):1261–1265
  69. Biel MA. Photodynamic therapy and the treatment of head and neck neoplasia. Laryngoscope. 1998;108(9):1259–1268
  70. Schweitzer VG. Photofrin-mediated photodynamic therapy for treatment of aggressive head and neck nonmelanomatous skin tumors in elderly patients. Laryngoscope. 2001;111:1091–1098
  71. Allison R, Sibata C, Childs C, et al. Low dose Photofrin® PDT for head and neck patients. In: 10th Congress of the International Photodynamic Association, Munich, Germany (Abstract). 2005.
  72. Tanaka H, Hashimoto K, Yamada I, et al. Interstitial photodynamic therapy with rotating and reciprocating optical fibers. Cancer. 2001;91(9):1791–1796
  73. Marcus SL, Sobel RS, Golub AL, et al. Photodynamic therapy (PDT) and photodiagnosis (PD) using endogenous photosensitization induced by 5-aminolevulinic acid (ALA): current clinical and development status. J Clin Laser Med Surg. 1996;14(2):59–66
  74. Grant WE, Hopper C, Macrobert AJ. Photodynamic therapy of oral cancer: photosensitization with systemic aminolevulinic acid. Lancet. 1993;342:147–148
  75. Fan KF, Hopper C, Speight PM, et al. Photodynamic therapy using 5-aminolevulinic acid for premalignant and malignant lesions of the oral cavity. Cancer. 1996;78(7):1374–1383
  76. Sieron A, Namyslowski G, Misiolek M, et al. Photodynamic therapy of premalignant lesions and local recurrence of laryngeal and hypopharyngeal cancers. Eur Arch Otorhinolaryngol. 2001;258(7):349–352
  77. Poate TW, Dilkes MG, Kenyon GS. Use of photodynamic therapy for the treatment of squamous cell carcinoma of the soft palate. Br J Oral Maxillofac Surg. 1996;34(1):66–68
  78. Dilkes M, McGilligan JA. Adjunctive intraoperative photodynamic therapy and microvascular anastomoses. Arch Otolaryngol Head Neck Surg. 1997;123(8):888
  79. Dilkes MG, DeJode ML, Gardiner Q, et al. Treatment of head and neck cancer with photodynamic therapy: results after one year. J Laryngol Otol. 1995;109(11):1072–1076
  80. Dilkes MG, DeJode ML, Rowntree-Taylor A, et al. m-THPC photodynamic therapy for head and neck cancer. Lasers Med Sci. 1996;11:23–29
  81. Dilkes MG, Benjamin E, Ovaisi S, et al. Treatment of primary mucosal head and neck squamous cell carcinoma using photodynamic therapy: results after 25 treated cases. J Laryngol Otol. 2003;117(9):713–717
  82. Grosjean P, Savary JF, Mizeret J, et al. Photodynamic therapy for cancer of the upper aerodigestive tract using tetra(m-hydroxyphenyl)chlorin. J Clin Laser Med Surg. 1996;14(5):281–287
  83. Savary JF, Monnier P, Fontolliet C, et al. Photodynamic therapy for early squamous cell carcinomas of the esophagus, bronchi, and mouth with m-tetra (hydroxyphenyl) chlorin. Arch Otolaryngol Head Neck Surg. 1997;123(2):162–168
  84. Fan KF, Hopper C, Speight PM, et al. Photodynamic therapy using mTHPC for malignant disease in the oral cavity. Int J Cancer. 1997;73(1):25–32
  85. Kubler AC, de Carpentier J, Hopper C, et al. Treatment of squamous cell carcinoma of the lip using Foscan-mediated photodynamic therapy. Int J Oral Maxillofac Surg. 2001;30(6):504–509
  86. Copper MP, Tan IB, Oppelaar H, et al. Meta-tetra(hydroxyphenyl)chlorin photodynamic therapy in early-stage squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg. 2003;129(7):709–711
  87. Hopper C, Kubler A, Lewis H, et al. mTHPC-mediated photodynamic therapy for early oral squamous cell carcinoma. Int J Cancer. 2004;111(1):138–146
  88. Tan B. Foscan mediated photodynamic therapy in recurrent and second primary oral cavity cancers. Laryngo-Rhino-Otology. 2000;79(s):318
  89. D’Cruz AK, Robinson MH, Biel MA. mTHPC-mediated photodynamic therapy in patients with advanced, incurable head and neck cancer: a multicenter study of 128 patients. Head Neck. 2004;26(3):232–240
  90. Lou PJ, Jager HR, Jones L, et al. Interstitial photodynamic therapy as salvage treatment for recurrent head and neck cancer. Br J Cancer. 2004;91(3):441–446
  91. Suhr MA, Hopper C, MacRobert AJ, et al. [Clinical pilot study of interstitial photodynamic therapy for treatment of advanced head and neck tumors]. Mund Kiefer Gesichtschir. 2001;5(5):277–282
  92. Hopper C, Niziol C, Sidhu M. The cost-effectiveness of Foscan mediated photodynamic therapy (Foscan-PDT) compared with extensive palliative surgery and palliative chemotherapy for patients with advanced head and neck cancer in the UK. Oral Oncol. 2004;40(4):372–382
  93. Sibata C, Bonnerup C, White K, et al. Optical flux density mapping of PDT sources using digital imaging. in ASLMS 2005. Orlando: American Society of Laser Medicine Surgery; 2005.
  94. Sieron A, Adamek M, Kawczyk-Krupka A, et al. Photodynamic therapy (PDT) using topically applied delta-aminolevulinic acid (ALA) for the treatment of oral leukoplakia. J Oral Pathol Med. 2003;32(6):330–336
  95. Vogl TJ, Eichler K, Mack MG, et al. Interstitial photodynamic laser therapy in interventional oncology. Eur Radiol. 2004;14(6):1063–1073
  96. Andry G, Hamoir M, Leemans CR. The evolving role of surgery in the management of head and neck tumors. Curr Opin Oncol. 2005;17(3):241–248
  97. Kovacs AF, Landes CA, Hamscho N, et al. Sentinel node biopsy as staging tool in a multimodality treatment approach to cancer of the oral cavity and the oropharynx. Otolaryngol Head Neck Surg. 2005;132(4):570–576
  98. Buchanan RB, Carruth JA, McKenzie AL, et al. Photodynamic therapy in the treatment of malignant tumours of the skin and head and neck. Eur J Surg Oncol. 1989;15(5):400–406
  99. Schweitzer VG. Photodynamic therapy improves Kaposi's sarcoma in AIDS patients. Am Fam Physician. 1988;38(5):260
  100. Shikowitz MJ, Abramson AL, Steinberg BM, et al. Clinical trial of photodynamic therapy with meso-tetra (hydroxyphenyl) chlorin for respiratory papillomatosis. Arch Otolaryngol Head Neck Surg. 2005;131(2):99–105

PII: S1572-1000(05)00092-X

doi: 10.1016/S1572-1000(05)00092-X

Photodiagnosis and Photodynamic Therapy
Volume 2, Issue 3 , Pages 205-222 , September 2005